Thermo Fisher Scientific to Acquire Clario Holdings
October 29, 2025
Thermo Fisher Scientific has agreed to acquire Clario Holdings, a digital clinical endpoint data solutions company, for $8.875 billion in cash plus up to $400 million in performance-based earnout payments. The deal is expected to close by mid-2026 pending regulatory approvals and would integrate Clario into Thermo Fisher’s Laboratory Products and Biopharma Services segment.
- Targets
- Clario Holdings, Inc., Clario Holdings
- Sellers
- Astorg, Nordic Capital, Novo Holdings, Cinven, a shareholder group led by Astorg, Nordic Capital, Novo Holdings, and Cinven
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.